Applications published 9 May 2007
Cancer selective auxotrophs
AntiCancer 1781096*
Liver disease-related methods and systems
Bayer HealthCare 1781097*
Antimicrobial devices and compsns
Acrymed 1781098*
Methods and reagents for treating honeybees for parasitic mites
Swanson, Melvin 1781099*
Novel nucleoside derivatives
Metabasis Therapeutics 1781101*
Muscarinic acetylcholine receptor antagonists
Glaxo Group 1781103*
Muscarinic acetylcholine receptor antagonists
Glaxo Group 1781104*
Glyphosate salt herbicidal compsns
Monsanto Technology 1781105*
Herbal pharmaceutical compsns for prophylaxis and/or treatment of cardiovascular diseases and the method of preparing the same
Sun Ten Phytotech 1781107*
Use of methyl pyruvate for the purpose of increasing muscle energy production
Antosh, Stanley 1781108*
Polyvinyl alcohol gels, especially in situ gelling agents
InnoCEL 1781251*
Method for producing coated drugs having a stable profile for the release of active agents
Roehm 1781252*
Preparation of pharmaceutical compsns containing nanoparticles
Warner-Lambert 1781253*
Pulmonary delivery of inhibitors of phosphodiesterase type 5
Mannkind Corp 1781254*
Compsns and methods for treating leukemia
Inex Pharmaceuticals Corp 1781255*
Phospholipid gel compsns for drug delivery and methods of treating conditions using the same
Idexx Laboratories 1781256*
Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
Emisphere Technologies 1781257*
Formulations of bisphosphonates
Mepha 1781258*
Improved stearate compsn and method of production thereof
Mallinckrodt 1781259*
Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
Boehringer Ingelheim International 1781260*
Modified release formulation of memantine
Forest Laboratories 1781261*
Pharmaceutical multilayer tablet for controlled release of active ingredients with highly pH-dependent solubility
Sanofi-Aventis 1781262*
Medicament in a multilayer form
Roehm 1781263*
Methods for manufacturing delivery devices and devices thereof
Brookwood Pharmaceuticals 1781264*
Pharmaceutical formulations of potassium ATP channel openers and uses thereof
Essentials 1781265*
Microprojection array patch for transdermal delivery of vascular endothelial growth factors
Alza Corp 1781266*
Methods and reagents for the treatment of inflammatory disorders
CombinatoRx 1781267*
Treatment of myocardial infarctions with 11HSD1 inhibitors
The University of Edinburgh 1781268*
IgE-retargeting, function-altering molecules (EFAM) for treatment of allergic diseases
St Mary's Hospital NHS Trust; Imperial College Innovations 1781269*
Resorcinol derivatives for lowering blood pressure
Yissum Research Development Company of the Hebrew University of Jerusalem 1781270*
Arylidenes for the treatment of estrogen-related receptor-alpha mediated diseases
Janssen Pharmaceutica 1781271*
Use of compounds active on the sigma receptor for the treatment of mechanical allodynia
Laboratoires del Dr Esteve 1781272*
Memantine as adjunctive treatment of atypical antipsychotics in schizophrenia patients
Forest Laboratories 1781273*
Novel bioaromatic compounds with activate receptors of PPAR type and their use in cosmetic or pharmaceutical compsns
Galderma Research & Development 1781274*
Sustained release pharmaceutical compsn of tolterodine
KRKA 1781275*
Use of peptide compounds for treating bone cancer pain, chemotherapy- and nucleoside-induced pain
Schwarz Pharma 1781276*
A combination compsn
AFT Pharmaceuticals 1781277*
Compsns and methods for treating eye disorders and conditions
Schepens Eye Research; Johnson & Johnson Vision Care 1781278*
Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders
Tech, Egon 1781279*
Androgen modulators
Warner-Lambert 1781280*
Compsns for urinary dysfunction and edema containing decursin and/or decursinol angelate, or angelica extract containing decusin and/or decursinol angelate
Han, Sang-Pil; Hanssem Health; Yoo, Eui-Jae 1781281*
Compsn for stabilising vitamin C in water phase and method for stabilising vitamin C using thereof
DPI Solutions 1781282*
Inhibition of voluntary ethanol consumption with non-peptidyl melanocortin 4-receptor agonists
Merck 1781283*
Use of the combination comprising temozolomide and TNF-alpha for treating glioblastoma
The University of Chicago; Dana-Farber Cancer Institute 1781284*
Mitotic kinesin inhibitors
Merck & Co 1781285*
Mitotic kinesin inhibitors
Merck & Co 1781286*
Thiazole based inhibitors of ATP-utilising enzymes
Genentech 1781287*
Modulators of muscarinic receptors
Vertex Pharmaceuticals 1781288*
Thienopyridines for treating hepatitis C
PTC Therapeutics; Karp, Gary Mitchell; Chen, Guangming 1781289*
Anti-inflammatory agents
Cambridge Enterprise 1781290*
Opioids for the treatment of the restlessness of the lower limbs
Euro-Celtique 1781291*
Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1benzopyran-2-one
Solvay Pharmaceuticals 1781292*
Quinoline- and isoquinoline-based compounds exhibiting ATP-utilising enzyme inhibitory activity, and compsns, and uses thereof
Amphora Discovery 1781293*
Compsn and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
Taro Pharmaceutical Industries 1781294*
Pharmaceutical compsn in the form of gastric-resident tablet containing an active principle
Sanofi-Aventis 1781295*
Quinazoline derivatives and their use in the treatment of thrombocythemia
Shire Holdings 1781296*
Novel biaromatic compounds that activate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compsns
Galderma Research & Development 1781297*
Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
Boehringer Ingelheim International 1781298*
Anti-inflammatory agents
Cambridge Enterprise 1781299*
Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases
ProteoSys 1781300*
Angiostatic agents for controlling choroidal neovascularisation after ocular surgery or trauma
Alcon 1781301*
New use
Lipopeptide 1781302*
Methods and treatments for the treatment of metabolic disorders
CombinatoRx 1781303*
Use of organic glucosamine salts
Bioiberica 1781304*
Compsns and methods using hyaluronic acid and hyaluronidase inhibitors
Angiotech International; University of British Columbia 1781305*
Immune stimulatory infant nutrition
NV Nutricia 1781306*
Immune stimulatory infant nutrition
NV Nutricia 1781307*
Natural anti-virus and compsn comprising thereof
Cotdel; Jiksan-eup, Cheonan; Lee, Jung-Hwa 1781308*
Nelumbinis semen extract for preventing and treating ischaemic heart disease and pharmaceutical compsn and health food containing the same
Purimed 1781309*
Articles of peptide nanostructures and method for forming the same
Ramot at Tel Aviv University 1781310*
Growth-hormone secretagogues
Elixir Pharmaceuticals 1781311*
Formulations and methods for modulating satiety
Rosenburg, Mark 1781312*
Mycobacterium tuberculosis epitopes and methods of use thereof
Beckman Coulter 1781313*
Compsns that inhibit HSP90 protein-protein interactions with IAP proteins
University of Massachusetts 1781314*
Peptide inhibitors for mediating stress responses
Yeda Research And Development Company, Weizmann Institute of Science 1781315*
Cyclic peptides for treatment of cachexia
Palatin Technologies 1781316*
Treatment of transformed or infected biological cells
Eberhard-Karls-Universitaet Tuebingen 1781317*
Methods and compsns for the treatment of polycystic diseases
Genzyme 1781318*
Method for enhancing bone formation
The Trustees of Columbia University in the City of New York 1781319*
Use of thyrotropin for regeneration of bone
Genzyme; Sampath, Kuber; McPherson, John 1781320*
A method of treating cancer comprising a VEG-F antagonist
Amrad Operations 1781321*
Method for treating diabetes
GroPep 1781322*
Compsn comprising a pulmonary surfactant and a TNF-derived peptide
Altana Pharma 1781323*
Pharmaceutically active insulin receptor-modulating molecules
Novo Nordisk 1781324*
Immuno stimulating formulations for inducing enhanced interferon-gamma responses
CSL 1781325*